STADA Arzneimittel AG — M&A Activity 2011

May 19, 2011

News Details

Ad-hoc | 19 May 2011 18:54

STADA negotiating the purchase of a generics business in Switzerland

STADA Arzneimittel AG / Key word(s): Mergers & Acquisitions

19.05.2011 18:54

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

Bad Vilbel, May 19, 2011 - The Executive Board of STADA Arzneimittel AG has
today, on May 19, 2011, resolved to enter into concrete negotiations with
Spirig Pharma AG, a Swiss pharmaceuticals company based in Egerkingen,
Canton Solothurn, on the acquisition of Spirig's generics business in
Switzerland.

The portfolio for sale includes 56 prescription (Rx) and 15
non-prescription (OTC) and discretionary prescription (OTX) products. With
regard to the target products STADA estimates the current annual sales
volume to be approx. CHF 45 million. The acquisition under consideration
does not include any production facilities.

STADA aims to make a final decision on the acquisition opportunity within
the next three months.

Additional information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 / D -
61118 Bad Vilbel /
Tel.: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-506 / E-mail:
communications@stada.de /
Or visit us in the Internet at www.stada.com.

19.05.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Deutschland
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications@stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard);
Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart

End of Announcement DGAP News-Service

---